Isolation and characterization of functional Leishmania major virulence factor UDP-galactopyranose mutase

Biochemical and Biophysical Research Communications

Volumn 407, Issue 3, 2011, Pages 552-556

  Oppenheimer, Michelle ^a   Valenciano, Ana L ^a,b   Sobrado, Pablo ^a,c  

^a VIRGINIA POLYTECHNIC INSTITUTE AND STATE UNIVERSITY   (United States)

^b INSTITUTO TECNOLÓGICO DE COSTA RICA   (Costa Rica)

^c Fralin Life Science Institute   (United States)

Author keywords

Flavoenzymes; Galactofuranose; Leishmaniasis; Non redox reaction; UDP galactopyranose mutase

Indexed keywords

GALACTOFURANOSE; GALACTOPYRANOSE; GALACTOSE; UNCLASSIFIED DRUG; URIDINE DIPHOSPHATE; URIDINE DIPHOSPHATE GALACTOPYRANOSE MUTASE; VIRULENCE FACTOR;

ARTICLE; CATALYSIS; CELL SURFACE; ENZYME ACTIVITY; HOST PARASITE INTERACTION; ISOLATION PROCEDURE; LEISHMANIA MAJOR; MOLECULAR WEIGHT; NONHUMAN; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PURIFICATION; STRUCTURE ANALYSIS; ULTRAVIOLET RADIATION;

CLONING, MOLECULAR; HUMANS; INTRAMOLECULAR TRANSFERASES; LEISHMANIA MAJOR; MOLECULAR WEIGHT; RECOMBINANT PROTEINS; VIRULENCE FACTORS;

BACTERIA (MICROORGANISMS); LEISHMANIA MAJOR;

EID: 79954615170     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2011.03.057     Document Type: Article

References (30)

1. Kato H., Gomez E.A., Caceres A.G., Uezato H., Mimori T., Hashiguchi Y. Molecular epidemiology for vector research on leishmaniasis. Int. J. Environ. Res. Public Health 2010, 7:814-826.
2. WHO, World Health Report. (World Health Organization, Geneva, (2002).
3. Herwaldt B.L. Leishmaniasis. Lancet 1999, 354:1191-1199.
4. Bailey M.S., Lockwood D.N. Cutaneous leishmaniasis. Clin. Dermatol. 2007, 25:203-211.
5. Kedzierski L., Sakthianandeswaren A., Curtis J.M., Andrews P.C., Junk P.C., Kedzierska K. Leishmaniasis: current treatment and prospects for new drugs and vaccines. Curr. Med. Chem. 2009, 16:599-614.
6. Suzuki E., Tanaka A.K., Toledo M.S., Takahashi H.K., Straus A.H. Role of beta-d-galactofuranose in Leishmania major macrophage invasion. Infect. Immun. 2002, 70:6592-6596.
7. de Lederkremer R.M., Colli W. Galactofuranose-containing glycoconjugates in trypanosomatids. Glycobiology 1995, 5:547-552.
8. Butcher B.A., Turco S.J., Hilty B.A., Pimenta P.F., Panunzio M., Sacks D.L. Deficiency in beta1, 3-galactosyltransferase of a Leishmania major lipophosphoglycan mutant adversely influences the Leishmania-sand fly interaction. J. Biol. Chem. 1996, 271:20573-20579.
9. A. Svarovska, T.H. Ant, V. Seblova, L. Jecna, S.M. Beverley, and P. Volf, Leishmania major glycosylation mutants require phosphoglycans (lpg2-) but not lipophosphoglycan (lpg1-) for survival in permissive sand fly vectors. PLoS Negl Trop Dis 4 e580.
10. Spath G.F., Garraway L.A., Turco S.J., Beverley S.M. The role(s) of lipophosphoglycan (LPG) in the establishment of Leishmania major infections in mammalian hosts. Proc. Natl. Acad. Sci. USA 2003, 100:9536-9541.
11. Turco S.J., Spath G.F., Beverley S.M. Is lipophosphoglycan a virulence factor? A surprising diversity between Leishmania species. Trends Parasitol. 2001, 17:223-226.
12. Suzuki E., Tanaka A.K., Toledo M.S., Levery S.B., Straus A.H., Takahashi H.K. Trypanosomatid and fungal glycolipids and sphingolipids as infectivity factors and potential targets for development of new therapeutic strategies. Biochim. Biophys. Acta 2008, 1780:362-369.
13. Beverley S.M., Owens K.L., Showalter M., Griffith C.L., Doering T.L., Jones V.C., McNeil M.R. Eukaryotic UDP-galactopyranose mutase (GLF gene) in microbial and metazoal pathogens. Eukaryot. Cell 2005, 4:1147-1154.
14. Bakker H., Kleczka B., Gerardy-Schahn R., Routier F.H. Identification and partial characterization of two eukaryotic UDP-galactopyranose mutases. Biol. Chem. 2005, 386:657-661.
15. Nassau P.M., Martin S.L., Brown R.E., Weston A., Monsey D., McNeil M.R., Duncan K. Galactofuranose biosynthesis in Escherichia coli K-12: identification and cloning of UDP-galactopyranose mutase. J. Bacteriol. 1996, 178:1047-1052.
16. Kleczka B., Lamerz A.C., van Zandbergen G., Wenzel A., Gerardy-Schahn R., Wiese M., Routier F.H. Targeted gene deletion of Leishmania major UDP-galactopyranose mutase leads to attenuated virulence. J. Biol. Chem. 2007, 282:10498-10505.
17. Madeira da Silva L., Owens K.L., Murta S.M., Beverley S.M. Regulated expression of the Leishmania major surface virulence factor lipophosphoglycan using conditionally destabilized fusion proteins. Proc. Natl. Acad. Sci. USA 2009, 106:7583-7588.
18. Blommel P.G., Martin P.A., Wrobel R.L., Steffen E., Fox B.G. High efficiency single step production of expression plasmids from cDNA clones using the Flexi Vector cloning system. Protein Expr. Purif. 2006, 47:562-570.
19. Sobrado P., Goren M.A., James D., Amundson C.K., Fox B.G. A Protein Structure Initiative approach to expression, purification, and in situ delivery of human cytochrome b5 to membrane vesicles. Protein Expr. Purif. 2008, 58:229-241.
20. Ohana R.F., Encell L.P., Zhao K., Simpson D., Slater M.R., Urh M., Wood K.V. HaloTag7: a genetically engineered tag that enhances bacterial expression of soluble proteins and improves protein purification. Protein Expr. Purif. 2009, 68:110-120.
21. Blommel P.G., Becker K.J., Duvnjak P., Fox B.G. Enhanced bacterial protein expression during auto-induction obtained by alteration of lac repressor dosage and medium composition. Biotechnol. Prog. 2007, 23:585-598.
22. Oppenheimer M., Poulin M.B., Lowary T.L., Helm R.F., Sobrado P. Characterization of recombinant UDP-galactopyranose mutase from Aspergillus fumigatus. Arch. Biochem. Biophys. 2010, 502:31-38.
23. Andrews P. Estimation of the molecular weights of proteins by Sephadex gel-filtration. Biochem. J. 1964, 91:222-233.
24. Sanders D.A.R., Staines A.G., McMahon S.A., McNeil M.R., Whitfield C., Naismith J.H. UDP-galactopyranose mutase has a novel structure and mechanism. Nat. Struct. Biol. 2001, 8:858-863.
25. Pan F., Jackson M., Ma Y., McNeil M. Cell wall core galactofuran synthesis is essential for growth of mycobacteria. J. Bacteriol. 2001, 183:3991-3998.
26. Schmalhorst P.S., Krappmann S., Vervecken W., Rohde M., Muller M., Braus G.H., Contreras R., Braun A., Bakker H., Routier F.H. Contribution of galactofuranose to the virulence of the opportunistic pathogen Aspergillus fumigatus. Eukaryot. Cell 2008, 7:1268-1277.
27. Soltero-Higgin M., Carlson E.E., Phillips J.H., Kiessling L.L. Identification of inhibitors for UDP-galactopyranose mutase. J. Am. Chem. Soc. 2004, 126:10532-10533.
28. Zhang Q., Liu H. Mechanistic investigation of UDP-galactopyranose mutase from Escherichia coli using 2- and 3-fluorinated UDP-galactofuranose as probes. J. Am. Chem. Soc. 2001, 123:6756-6766.
29. Chad J.M., Sarathy K.P., Gruber T.D., Addala E., Kiessling L.L., Sanders D.A. Site-directed mutagenesis of UDP-galactopyranose mutase reveals a critical role for the active-site, conserved arginine residues. Biochemistry 2007, 46:6723-6732.
30. Partha S.K., van Straaten K.E., Sanders D.A. Structural basis of substrate binding to UDP-galactopyranose mutase: crystal structures in the reduced and oxidized state complexed with UDP-galactopyranose and UDP. J. Mol. Biol. 2009, 394:864-877.